Chen, Y., Li, Q., Wen, Z., Ouyang, Y., Ji, Y., Huang, R., Lai, S., Wang, C., Li, M. Y., Lin, Q., Zhang, X., Chen, M. (2026). Guard-01: A randomized, open-label trial of efbemalenograstim alfa as primary prophylaxis for neutropenia during definitive concurrent chemo-radiotherapy.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.12060